These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10506765)
1. Significance of creatine kinase release after coronary interventions. Klein LW Catheter Cardiovasc Interv; 1999 Oct; 48(2):130-2. PubMed ID: 10506765 [No Abstract] [Full Text] [Related]
2. Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices. Kini A; Kini S; Marmur JD; Bertea T; Dangas G; Cocke TP; Sharma SK Catheter Cardiovasc Interv; 1999 Oct; 48(2):123-9. PubMed ID: 10506764 [TBL] [Abstract][Full Text] [Related]
3. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Shyu KG; Kuan PL; Cheng JJ; Hung CR Am Heart J; 1998 May; 135(5 Pt 1):862-7. PubMed ID: 9588418 [TBL] [Abstract][Full Text] [Related]
4. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). Harrington RA; Lincoff AM; Califf RM; Holmes DR; Berdan LG; O'Hanesian MA; Keeler GP; Garratt KN; Ohman EM; Mark DB J Am Coll Cardiol; 1995 Jun; 25(7):1693-9. PubMed ID: 7759725 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. Tardiff BE; Califf RM; Tcheng JE; Lincoff AM; Sigmon KN; Harrington RA; Mahaffey KW; Ohman EM; Teirstein PS; Blankenship JC; Kitt MM; Topol EJ J Am Coll Cardiol; 1999 Jan; 33(1):88-96. PubMed ID: 9935014 [TBL] [Abstract][Full Text] [Related]
6. New device angioplasty: the impact on restenosis. Wong CS; Leon MB; Popma JJ Coron Artery Dis; 1993 Mar; 4(3):243-53. PubMed ID: 8269218 [No Abstract] [Full Text] [Related]
7. Restenosis after coronary interventions and device specificity. Wijns W Eur Heart J; 1995 Oct; 16(10):1307-8. PubMed ID: 8746893 [No Abstract] [Full Text] [Related]
8. New technology in the catheterization lab. Ellis SG Cleve Clin J Med; 1992; 59(6):561-2. PubMed ID: 1424065 [No Abstract] [Full Text] [Related]
9. Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Garbarz E; Iung B; Lefevre G; Makita Y; Farah B; Michaud P; Graine H; Vahanian A Am J Cardiol; 1999 Sep; 84(5):515-8. PubMed ID: 10482147 [TBL] [Abstract][Full Text] [Related]
10. [PTCA or alternative techniques? Balloon angioplasty remains dominant]. Reifart N Z Kardiol; 1995; 84 Suppl 2():43-52. PubMed ID: 7571782 [TBL] [Abstract][Full Text] [Related]
11. Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality. Harrington RA J Am Coll Cardiol; 2000 Apr; 35(5):1142-4. PubMed ID: 10758953 [No Abstract] [Full Text] [Related]
12. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure. Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353 [TBL] [Abstract][Full Text] [Related]
13. Pursuit of large lumen dimensions after coronary intervention {editorial}. Kuntz RE; Baim DS; Safian RD J Interv Cardiol; 1993 Dec; 6(4):287-91. PubMed ID: 10151022 [No Abstract] [Full Text] [Related]
14. Prognostic significance of myocardial enzyme release after coronary interventions. Kelly D; Arora R Catheter Cardiovasc Interv; 1999 Mar; 46(3):292-302. PubMed ID: 10348125 [TBL] [Abstract][Full Text] [Related]
15. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Abdelmeguid AE; Topol EJ Circulation; 1996 Dec; 94(12):3369-75. PubMed ID: 8989153 [No Abstract] [Full Text] [Related]
16. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups. Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901 [TBL] [Abstract][Full Text] [Related]
17. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Abdelmeguid AE; Ellis SG; Sapp SK; Whitlow PL; Topol EJ Am Heart J; 1996 Jun; 131(6):1097-105. PubMed ID: 8644587 [TBL] [Abstract][Full Text] [Related]
18. Are residual stenoses after excimer laser angioplasty and coronary atherectomy due to inefficient or small devices? Comparison with balloon angioplasty. Safian RD; Freed M; Lichtenberg A; May MA; Juran N; Grines CL; O'Neill WW J Am Coll Cardiol; 1993 Nov; 22(6):1628-34. PubMed ID: 8227830 [TBL] [Abstract][Full Text] [Related]
19. Low incidence of minor myocardial damage associated with coronary stenting detected by serum troponin T comparable to that with balloon coronary angioplasty. Ohnishi N; Iwasaki K; Kusachi S; Hirami R; Matano S; Ohnishi H; Takeda K; Kita T; Sakakibara N; Tsuji T Jpn Heart J; 1998 Mar; 39(2):139-46. PubMed ID: 9687822 [TBL] [Abstract][Full Text] [Related]
20. Changing incidence and management of abrupt closure following coronary intervention in the new device era. Kuntz RE; Piana R; Pomerantz RM; Carrozza J; Fishman R; Mansour M; Safian RD; Baim DS Cathet Cardiovasc Diagn; 1992 Nov; 27(3):183-90. PubMed ID: 1423573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]